Revolutionizing Schizophrenia Treatment

This chapter discusses Cobinfi, a pioneering drug developed by Bristol-Myers that offers a new treatment for schizophrenia with reduced side effects. It also examines the drug's potential for other mental health disorders and the strategic focus on patient access and market impact.